GeneDx Director Acquires 12,924 Shares Through RSU Vesting, Holds $224K Position

GeneDx Holdings Corp. (WGS) director Joshua Ruch reported multiple transactions in a Form 4 filing dated June 28, 2025.

Rhea-AI Filing Summary

GeneDx Holdings Corp. (WGS) director Joshua Ruch reported multiple transactions in a Form 4 filing dated June 28, 2025. Key transactions include:

• Acquisition of 12,924 shares of Class A Common Stock through the conversion of Restricted Stock Units (RSUs) on June 18, 2025, at $0 cost
• Receipt of 3,576 new RSUs on June 18, 2025, which vest at the earlier of next annual shareholder meeting or first grant anniversary

Following these transactions, Ruch's beneficial ownership consists of:

• 29,723 shares held directly
• 194,267 shares held indirectly through various entities: - 14,845 via Kariba LLC - 30,138 via Rugu2 LLC - 149,284 via VAAL Investment Partners Q9 LP

Insider Trade Summary

12,924 shares exercised/converted

Exercise 6 txns

Insider RUCH JOSHUA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	3,576	$0.00	$0.00
Exercise	Restricted Stock Unit	12,924	$0.00	$0.00
Exercise	Class A Common Stock	12,924	$0.00	$0.00
holding	Class A Common Stock	--	--	--
holding	Class A Common Stock	--	--	--
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Unit — 3,576 contracts (Direct); Class A Common Stock — 29,723 shares (Direct); Class A Common Stock — 14,845 shares (Indirect, See Kariba LLC); Class A Common Stock — 30,138 shares (Indirect, See Rugu2 LLC); Class A Common Stock — 149,284 shares (Indirect, See VAAL Investment Partners Q9 LP)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2. F2. The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many WGS shares did Director Joshua Ruch acquire on June 18, 2025?

Director Joshua Ruch acquired 12,924 shares of WGS Class A Common Stock on June 18, 2025 through the settlement of Restricted Stock Units (RSUs). Additionally, he was granted 3,576 new RSUs on the same date.

What is the total amount of WGS shares Joshua Ruch owns directly and indirectly?

Following the reported transactions, Joshua Ruch owns 223,990 shares in total: 29,723 shares directly, and indirectly owns 14,845 shares through Kariba LLC, 30,138 shares through Rugu2 LLC, and 149,284 shares through VAAL Investment Partners Q9 LP.

When will Joshua Ruch's new WGS RSUs vest?

The RSUs will vest at the earlier of: (a) the date of the next annual meeting of GeneDx Holdings' shareholders following the grant date, or (b) the first anniversary of the grant date, subject to Ruch continuing to provide services to the company through the vesting date.

What was the exercise price of WGS RSUs granted to Joshua Ruch?

The RSUs were granted with no exercise price. Each RSU represents a contingent right to receive 1 share of GeneDx Holdings' Class A Common Stock upon settlement for no consideration ($0).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2025 - 05:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RUCH JOSHUA

(Last) (First) (Middle)

C/O GENEDX HOLDINGS CORP.

(Street)

STAMFORD CT 06902

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GeneDx Holdings Corp. [ WGS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/18/2025		M		12,924	A	$0(1)	29,723	D
Class A Common Stock								14,845	I	See Kariba LLC
Class A Common Stock								30,138	I	See Rugu2 LLC
Class A Common Stock								149,284	I	See VAAL Investment Partners Q9 LP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	06/18/2025		A		3,576		(2)	(2)	Class A Common Stock	3,576	$0	3,576	D
Restricted Stock Unit	(1)	06/18/2025		M			12,924	(2)	(2)	Class A Common Stock	12,924	$0	0	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.

2. The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.

	/s/ Bridget Brown, Attorney-in-Fact	06/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.